Assessment of T2 Hyperintens Focies in Case of Occurrence of Arterial Hypertension and Type 2 Diabetes Mellitus Together and Separately

Guluzade L.Ch.^1, , Sultanova M.C¹ and Gafarov I.A.²

¹Department of Radiology, Azerbaijan Medical University, Baku, Azerbaijan

²Department of medical and biological physics, Azerbaijan Medical University, Baku, Azerbaijan

Cite this paper

Guluzade L.Ch., Sultanova M.C and Gafarov I.A.. Assessment of T2 Hyperintens Focies in Case of Occurrence of Arterial Hypertension and Type 2 Diabetes Mellitus Together and Separately. American Journal of Medical and Biological Research. 2023; 11(1):1-6. doi: 10.12691/AJMBR-11-1-1

Abstract

Arterial Hypertension (AH) and type 2 Diabetes Mellitus(DM) have already become an epidemic in the last decades. Both of them are risk factors for formation of T2 hyperintense foci. MRI is the most convenient non-invasive method for detecting T2 hyperintense foci. Total of 275 patients between 35 and 70 years were included in this study. 77 of the patients were with only AH, 51 with only type 2 DM, 61 with AH + type 2 DM and 86 of them were healthy individuals. The purpose of the study is to note, compare (with each other and with control group) and check the statistical validity of the size and numbers of white matter hyperintensities (T2 hyperintense foci) detected in the brain in the presence of only AH or only type 2 DM and both pathologies together. The principles of randomization between age, gender (male, female) were followed. In patients with both AH and type 2 DM, the number of T2 hyperintense foci in the brain increases dramatically. When both diseases are present concurrently, the maximum and average size, number of foci are greater than those with AH or type 2 DM alone and control group. The cut-off for the average size of foci in patients with both AH and type 2 DM was 2.9 mm (sensitivity 73.2%±5.9%, specificity 92.2±3.8%), with only AH it was 1.9 mm (sensitivity 83.8%±4 .5%, specificity 52.9±7.0%), with only type 2 DM it was 2.9 mm for average size (sensitivity 45.7%±7 .3%, specificity 92.2±3.8%). The cut-off point for the number of foci in patients with both AH and type 2 DM is 23 (sensitivity 96.4±2.5%, specificity 98.0±1.9%), with only AH it was 14 (sensitivity 77.9±5.0%, specificity 94.1±3.3%), with only type 2 DM it was 14 (sensitivity 71.7±6.6%, specificity 94.1±3.3%).

Keywords

MRI, brain, T2 hyperintens foci, arterial hypertension, type 2 diabetes mellitus, diagnostic value, healthy

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Pavlovic, A. M., Pekmezovic, T., Trajkovic, J. Z., Tomic, G., Cvitan, E., & Sternic, N.. Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease. Journal of Clinical Hypertension (Greenwich, Conn.). 2018; 20(9), 1260-1265.
[2]	Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep. 2017; 19(3): 24.
[3]	Wang, L., Goldstein, F. C., Levey, A. I., Lah, J. J., Meltzer, C. C., Holder, C. A., & Mao, H. White matter hyperintensities and changes in white matter integrity in patients with Alzheimer’s disease. Neuroradiology. 2011; 53(5), 373-381.
[4]	Prins, N. D., & Scheltens, P.. White matter hyperintensities, cognitive impairment and dementia: an update. Nature Reviews. Neurology. 2015; 11(3), 157-165.
[5]	Smith, E. E., Schneider, J. A., Wardlaw, J. M. & Greenberg, S. M. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012; 11, 272-282.
[6]	Basile, A. M., Pantoni, L., Pracucci, G., Asplund, K., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J. M., Hennerici, M., O’Brien, J., Scheltens, P., Visser, M. C., Wahlund, L.-O., Waldemar, G., Wallin, A., Inzitari, D., & LADIS Study Group. (2006). Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovascular Diseases (Basel, Switzerland), 21(5-6), 315-322.
[7]	Wartolowska, K. A., & Webb, A. J. S. . Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study. European Heart Journal. 2021; 42(7), 750-757.
[8]	The SPRINT MIND Investigators for the SPRINT Research Group. Association of intensive vs. standard blood pressure control with cerebral white matter lesions. JAMA 2019; 322: 524-534.
[9]	Zhao, Y., Ke, Z., He, W., & Cai, Z. Volume of white matter hyperintensities increases with blood pressure in patients with hypertension //. (n.d.). The Journal of International Medical Research. 2019; 47(8), 3681-3689.
[10]	McEvoy, L. K., Fennema-Notestine, C., Eyler, L. T., Franz, C. E., Hagler, D. J., Jr, Lyons, M. J., Panizzon, M. S., Rinker, D. A., Dale, A. M., & Kremen, W. S. Hypertension-related alterations in white matter microstructure detectable in middle age. Hypertension/ 2015; 66(2), 317-323.
[11]	Sun, J., Xu, B., Zhang, X., He, Z., Liu, Z., Liu, R., & Nan, G.The mechanisms of type 2 diabetes-related white matter intensities: A review. Frontiers in Public Health. 2020; 8, 498056.
[12]	Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endoc Metab. 2016; 20:546.
[13]	Yang, C., DeVisser, A., Martinez, J. A., Poliakov, I., Rosales-Hernandez, A., Ayer, A., Garven, A., Zaver, S., Rincon, N., Xu, K., Tuor, U. I., Schmidt, A. M., & Toth, C. Differential impact of diabetes and hypertension in the brain: adverse effects in white matter. Neurobiology of Disease. 2011; 42(3), 446-458.
[14]	Colosia, A. D., Palencia, R., Khan, S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review // Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2013, 327-338.
[15]	de Havenon, A., Majersik, J. J., Tirschwell, D. L., McNally, J. S., Stoddard, G., & Rost, N. S. Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics. Neurology. 2019; 92(11), e1168-e1175.
[16]	Manning LS, Rothwell PM, Potter JF, Robinson TG. Prognostic significance of shortterm blood pressure variability in acute stroke systematic review. Stroke 2015;46: 2482-2490.
[17]	Gafarov I.A. Biostatistika, Baku, 2022, 240p. ISBN 978-9952-37-813-9.
[18]	Ahadov R., Gafarov I. Modern ideas about the influence of risk factors on mortality of patients receiving hemodialysis treatment with concomitant metabolic syndrome // European research, 2016, № 4 (15), p. 156-158.
[19]	Newby, D., Winchester, L., Sproviero, W., Fernandes, M., Wang, D., Kormilitzin, A., Launer, L. J., & Nevado-Holgado, A. J. Associations between brain volumes and cognitive tests with hypertensive burden in UK Biobank. Journal of Alzheimer’s Disease: JAD. 2021; 84(3), 1373-1389.
[20]	Cornelis MC, Wang Y, Holland T, Agarwal P, Weintraub S, Morris MC (2019) Age and cognitive decline in the UK Biobank. PLoS One 14, e0213948.
[21]	Tchistiakova, E., Anderson, N. D., Greenwood, C. E., & MacIntosh, B. J. Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults. NeuroImage. Clinical. 2014; 5, 36-41.
[22]	World health organization: [Electronic resource] / - August 25, 2021. URL: https://www.who.int/news-room/fact-sheets/detail/hypertension.
[23]	Tosun A., Serifoglu I., Cakir B. Behaviors Of Cerebral Microbleedings on T2 Weighted Gradient Echo Magnetic Resonance Imaging Turk J Health S. 2021; 2(2): 7-12.